Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.

Leslie LK, Alexander ME, Trikalinos TA, Cohen JT, Parsons SK, Newburger JW.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232. No abstract available.

2.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
3.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
4.

Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults.

Gibbins C, Weiss M.

Curr Psychiatry Rep. 2007 Oct;9(5):420-6. Review.

PMID:
17915083
5.

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder.

Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG.

J Am Acad Child Adolesc Psychiatry. 2000 Jul;39(7):920-7. Review.

PMID:
10892235
6.

[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].

Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.

Neuropsychiatr. 2007;21(3):187-206. Review. German.

PMID:
17915180
7.

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry.

J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. Review.

PMID:
11833633
8.

Clinical management of attention deficit hyperactivity disorder.

Voeller KK.

J Child Neurol. 1991;6 Suppl:S51-67. Review.

PMID:
1672134
9.

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.

Warren AE, Hamilton RM, Bélanger SA, Gray C, Gow RM, Sanatani S, Côté JM, Lougheed J, LeBlanc J, Martin S, Miles B, Mitchell C, Gorman DA, Weiss M, Schachar R.

Can J Cardiol. 2009 Nov;25(11):625-30. Review.

10.

Attention deficit/hyperactivity disorder: working the system for better diagnosis and treatment.

Stevens S.

J Pediatr Nurs. 2005 Feb;20(1):47-51. Review. No abstract available.

PMID:
15834359
11.

Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.

Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK, Gillberg C, Huss M, Jensen P, Kennedy JL, Klein R, Rapoport J, Sagvolden T, Spencer T, Swanson JM, Volkow N.

J Atten Disord. 2002;6 Suppl 1:S89-100. Review.

PMID:
12685523
12.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
13.

[Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].

Rollini M, Baud P.

Rev Med Suisse. 2008 Jul 16;4(165):1638-43. Review. French.

PMID:
18767289
14.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
15.

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.

Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG.

J Am Acad Child Adolesc Psychiatry. 2000 Jul;39(7):908-19. Review.

PMID:
10892234
16.
17.

Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.

Barzman DH, Fieler L, Sallee FR.

J Leg Med. 2004 Mar;25(1):23-38. Review. No abstract available.

PMID:
15208788
18.
19.

[Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].

Lehmkuhl G.

MMW Fortschr Med. 2007 May 21;149 Suppl 2:10-3; quiz 14. Review. German.

PMID:
17724960
20.

Stimulant drugs.

Santosh PJ, Taylor E.

Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I27-43. Review.

PMID:
11140778

Supplemental Content

Support Center